In vivo Candida glabrata biofilm development on foreign bodies in a rat subcutaneous model

Journal of Antimicrobial Chemotherapy

Volumn 70, Issue 3, 2015, Pages 846-856

  Kucharíková, Soňa ^a   Neirinck, Bram ^a   Sharma, Nidhi ^a,b   Vleugels, Jef ^a   Lagrou, Katrien ^a   Van Dijck, Patrick ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b BANASTHALI UNIVERSITY   (India)

Author keywords

C. glabrata; Echinocandins; Fluconazole; In vitro biofilms; In vivo biofilms

Indexed keywords

ECHINOCANDIN; FLUCONAZOLE; POLYSTYRENE; ANTIFUNGAL AGENT; FUNGAL PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; AWP1 GENE; AWP2 GENE; AWP3 GENE; AWP4 GENE; AWP5 GENE; AWP6 GENE; AWP7 GENE; BIOFILM; CANDIDA GLABRATA; CONFOCAL LASER MICROSCOPY; EPA1 GENE; EPA3 GENE; EPA6 GENE; EXTRACELLULAR MATRIX; FEMALE; FOREIGN BODY; FUNGAL GENE; FUNGAL STRAIN; FUNGUS GROWTH; GENE EXPRESSION PROFILING; IN VITRO STUDY; IN VIVO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; RAT; REAL TIME POLYMERASE CHAIN REACTION; SCANNING ELECTRON MICROSCOPY; TRIPLE LUMEN CATHETER; ANIMAL; CANDIDIASIS; COMPLICATION; CONFOCAL MICROSCOPY; DISEASE MODEL; DRUG EFFECTS; GENETICS; GROWTH, DEVELOPMENT AND AGING; MICROBIOLOGY; PATHOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; TREATMENT OUTCOME;

ANIMALS; ANTIFUNGAL AGENTS; BIOFILMS; CANDIDA GLABRATA; CANDIDIASIS; DISEASE MODELS, ANIMAL; ECHINOCANDINS; FEMALE; FLUCONAZOLE; FOREIGN BODIES; FUNGAL PROTEINS; GENE EXPRESSION PROFILING; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, SCANNING; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; TREATMENT OUTCOME;

EID: 84928190226     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dku447     Document Type: Article

References (50)

1. Silva S, Negri M, Henriques M et al. Silicone colonization by non-Candida albicans Candida species in the presence of urine. J Med Microbiol 2010; 59: 747-54.
2. Mikulska M, Del Bono V, Ratto S et al. Occurrence, presentation and treatment of candidemia. Expert Rev Clin Immunol 2012; 8: 755-65.
3. Falagas ME, Roussos N, Vardakas KZ. Relative frequency of albicans and the various non-albicans Candida spp among candidemia isolates from inpatients in various parts of the world: a systematic review. Int J Infect Dis 2010; 14: e954-e66.
4. Weiss CA 3rd, Statz CL, Dahms RA et al. Six years of surgical wound infection surveillance at a tertiary care center: review of the microbiologic and epidemiological aspects of 20,007 wounds. Arch Surg 1999; 134: 1041-8.
5. Pfaller MA, Diekema DJ. Epidemiology of invasive mycoses in North America. Crit Rev Microbiol 2010; 36: 1-53.
6. Pfaller MA. Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment. Am J Med 2012; 125 Suppl: S3-13.
7. Schwarzmüller T, Ma B, Hiller E et al. Systematic phenotyping of a large-scale Candida glabrata deletion collection reveals novel antifungal tolerance genes. PloS Pathog 2014; 10: e1004211.
8. Lass-Flörl C. Triazole antifungal agents in invasive fungal infections: a comparative review. Drugs 2011; 71: 2405-19.
9. Silva S, Negri M, Henriques M et al. Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance. FEMS Microbiol Rev 2012; 36: 288-305.
10. Flevari A, Theodorakopoulou M, Velegraki A et al. Treatment of invasive candidiasis in the elderly: a review. Clin Interv Aging 2013; 8: 1199-208.
11. de Groot PW, Bader O, de Boer AD et al. Adhesins in human fungal pathogens: glue with plenty of stick. Eukaryot Cell 2013; 12: 470-81.
12. Cormack BP, Ghori N, Falkow S. An adhesin of the yeast pathogen Candida glabrata mediating adherence to human epithelial cells. Science 1999; 285: 578-82.
13. De Las Peñas A, Pan SJ, Castaño I et al. Virulence-related surface glycoproteins in the yeast pathogen Candida glabrata are encoded in subtelomeric clusters and subject to RAP1-and SIR-dependent transcriptional silencing. Genes Dev 2003; 17: 2245-58.
14. Gallegos-García V, Pan S-J, Juárez-Cepeda J et al. A novel downstream regulatory element cooperates with the silencing machinery to repress EPA1 expression in Candida glabrata. Genetics 2012; 190: 1285-97.
15. Castaño I, Pan SJ, Zupacic M et al. Telomere length control and transcriptional regulation of subtelomeric adhesins in Candida glabrata. Mol Microbiol 2005; 55: 1246-58.
16. Domergue R, Castaño I, De Las Peñas A et al. Nicotinic acid limitation regulates silencing of Candida adhesins during UTI. Science 2005; 308: 866-70.
17. Iraqui I, Garcia-Sanchez S, Aubert S et al. The YAK1p kinase controls expression of adhesins and biofilm formation in Candida glabrata in a Sir4p-dependent pathway. Mol Microbiol 2005; 55: 1259-71.
18. Kucharíková S, Tournu H, Lagrou K et al. Detailed comparison of Candida albicans and Candida glabrata biofilms under different conditions and their susceptibility to caspofungin and anidulafungin. J Med Microbiol 2011; 60: 1261-9.
19. Kraneveld EA, de Soet JJ, Deng DM et al. Identification and differential gene expression of adhesin-like wall proteins in Candida glabrata biofilms. Mycopathologia 2011; 172: 415-27.
20. de Groot PW, Kraneveld EA, Yin QY et al. The cell wall of the human pathogen Candida glabrata: differential incorporation of novel adhesin-like wall proteins. Eukaryot Cell 2008; 7: 1951-64.
21. Blankenship JR, Mitchell AP. How to build a biofilm: a fungal perspective. Curr Opin Microbiol 2006; 9: 588-94.
22. Seneviratne CJ, Silva WJ, Jin LJ et al. Architectural analysis, viability assessment and growth kinetics of Candida albicans and Candida glabrata biofilms. Arch Oral Biol 2009; 54: 1052-60.
23. Silva S, Henriques M, Martins A et al. Biofilms of non-Candida albicans Candida species: quantification, structure and matrix composition. Med Mycol 2009; 47: 681-9.
24. Kojic EM, Darouiche RO. Candida infections on medical devices. Clin Microbiol Rev 2004; 17: 255-67.
25. Van Acker H, Van Dijck P, Coenye T. Molecular mechanisms of antimicrobial tolerance and resistance in bacterial and fungal biofilms. Trends Microbiol 2014; 22: 326-33.
26. Mathé L, Van Dijck P. Recent insights into Candida albicans biofilm resistance mechanisms. Curr Genet 2013; 59: 251-64.
27. Hawser SP, Douglas LJ. Biofilm formation by Candida species on the surface of catheter materials in vitro. Infect Immun 1994; 62: 915-21.
28. Nikawa H, Nishimura H, Hamada T et al. Effects of dietary sugars and, saliva and serum on Candida biofilm formation on acrylic surfaces. Mycopathologia 1997; 139: 87-91.
29. Shin JH, Kee SJ, Shin MG et al. Biofilm production by isolates of Candida species recovered from nonneutropenic patients: comparison of bloodstream isolates with isolates from other sources. J Clin Microbiol 2002; 40: 1244-8.
30. Thein ZM, Samaranayake YH, Samaranayake LP. In vitro biofilm formation of Candida albicans and non-albicans Candida species under dynamic and anaerobic conditions. Arch Oral Biol 2007; 52: 761-7.
31. Parahitiyawa NB, Samaranayake YH, Samaranayake LP et al. Interspecies variation in Candida biofilm formation studied using the Calgary biofilm device. APMIS 2006; 114: 298-306.
32. Silva S, Henriques M, Oliveira R et al. In vitro biofilm activity of non-Candida albicans Candida species. Curr Microbiol 2010; 59: 747-54.
33. Estivill D, Arias A, Torres-Lana A et al. Biofilm formation by five species of Candida on three clinical materials. J Microbiol Methods 2011; 86: 238-42.
34. Seidler M, Salvenmoser S, Müller FM. In vitro effects of micafungin against Candida biofilms on polystyrene and central venous catheter sections. Int J Antimicrob Agents 2006; 28: 568-73.
35. Bernhardt H, Knoke M, Bernhardt J. Efficacy of anidulafungin against biofilms of different Candida species in long-term trials of continuous flow cultivation. Mycoses 2011; 54: e821-7.
36. Toulet D, Debarre C, Imbert C. Could liposomal amphotericin B (L-AMB) lock solutions be useful to inhibit Candida spp. biofilms on silicone biomaterials? J Antimicrob Chemother 2012; 67: 430-2.
37. Nett J, Lincoln L, Marchillo K et al. b-1,3 Glucan as a test for central venous catheter biofilm infection. J Infect Dis 2007; 195: 1705-12.
38. Paulitsch AH, Willinger B, Zsalatz B et al. In vivo Candida biofilms in scanning electron microscopy. Med Mycol 2009; 47: 690-6.
39. Řičicová M, Kucharíková S, Tournu H et al. Candida albicans biofilm formation in a new in vivo rat model. Microbiology 2010; 156: 909-19.
40. Kucharíková S, Tournu H, Holtappels M et al. In vivo efficacy of anidulafungin against Candida albicans mature biofilms in a novel rat model of catheter-associated candidiasis. Antimicrob Agents Chemother 2010; 54: 4474-8.
41. Kucharíková S, Sharma N, Spriet I et al. Activities of systematically administered echinocandins against in vivo mature Candida albicans biofilms developed in a rat subcutaneous model. Antimicrob Agents Chemother 2013; 57: 2365-8.
42. Clinical and Laboratory Standards Institute. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts: Fourth Informational Supplement M27-S4. CLSI, Wayne, PA, USA, 2012.
43. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 22DDC(T) method. Methods 2001; 25: 402-8.
44. Kucharíková S, Van Dijck P, Lisalová M et al. Effect of antifungals on itraconazole resistant Candida glabrata. Central Eur J Biol 2010; 5: 318-23.
45. Pfaller MA, Diekema DJ, Gibbs DL et al. Results from the ARTEMIS DISK global antifungal surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing. J Clin Microbiol 2007; 45: 1735-45.
46. Rodrigues CF, Silva S, Henriques M. Candida glabrata: a review of its features and resistance. Eur J Clin Microbiol Infect Dis 2014; 33: 673-88.
47. Pierce CG, Lopez-Ribot JL. Candidiasis drug discovery and development: new approaches targeting virulence for discovering and identifying new drugs. Expert Opin Drug Discov 2013; 8: 1117-26.
48. Lazzell AL, Chaturvedi AK, Pierce CG et al. Treatment and prevention of Candida albicans biofilms with caspofungin in a novel central venous catheter murine model of candidiasis. J Antimicrob Chemother 2009; 64: 567-70.
49. Pfaller MA, Castanheira M, Lockhart SR et al. Frequency of decreased susceptibility and resistance to echinocandins among fluconazoleresistant bloodstream isolates of Candida glabrata. J Clin Microbiol 2012; 50: 1199-203.
50. Vande Velde G, Kucharíková S, Schrevens S et al. Towards non-invasive monitoring of pathogen-host interactions during Candida albicans biofilm formation using in vivo bioluminescence. Cell Microbiol 2014; 16: 115-30.